Karachi Kings crush Lahore Qalandars by 67 runs 

Karachi, February 20, 2023 (PPI-OT):Karachi Kings steamrolled Lahore Qalandars to record their biggest win in the HBL Pakistan Super League history – by 67 runs – at the National Bank Cricket Arena on Sunday evening. Chasing an imposing 186, Lahore Qalandars, playing their second match after defeating Multan Sultans in the opener, were all out for 118 in 17.3 overs. This is Karachi Kings’ first win in four matches this edition.

Karachi Kings’ decision to open with overseas openers in Matthew Wade and James Vince paid dividends as the pair posted the side’s highest Powerplay score of this edition – 61 for none. Wade and Vince had set a perfect platform for their side to post a towering total before their 71-run partnership came to a halt because of a run out at the start of the eighth over with Wade falling short in his bid to take the second run. The Australian wicketkeeper-batter made 36 off 24.

A 32-run partnership between Vince and Haider Ali (18 off 16) followed that denied the visiting bowlers further inroads. A flurry of wickets reduced Karachi Kings to 124 for four from 102 for one with Haider, Shoaib Malik (10 off seven) and Vince (46 off 36) walking back to the pavilion.

Lahore Qalandars, however, failed to make the most of this turnaround and Imad Wasim, the Karachi Kings skipper, once again displayed the explosive side of his batsmanship with a splendid 35 not out off 19, studded with two sixes and as many fours. He was duly supported by Ben Cutting, 20 off 19, as the pair added 52 off 35 and lifted the home side to 185 for five.

Lahore Qalandars had a decent beginning to the run chase with Fakhar Zaman and Mirza Tahir Baig racing their side to 40, before the former was bowled by Aamer Yamin at 4.2 overs mark. Muhammad Irfan Khan took a marvellous catch at backward point in the next over off Mohammad Amir to restrict Shai Hope’s stay to just two balls, off which he scored one, as the problems now compounded for the Qalandars.

A 41-run partnership between Tahir and Kamran Ghulam (23 off 22) followed, but the pair failed to keep up with the scoring rate. One after the other, both batters were sent back to the pavilion by Akif Javed in the 13th over and when Kamran, the last of the two, was caught, Lahore Qalandars required 99 off only 44.

That proved to be the turning point of the match and from there on, no Lahore Qalandars batter could put up resistance. Akif finished with four for 28. Aamer and Cutting took two wickets each.

Lahore has a chance to avenge the defeat when the two teams meet in Lahore on 12 March – the last match of the league stage.

Scores in brief:

Karachi Kings 185-5, 20 overs (James Vince 46, Matthew Wade 36, Imad Wasim 35 not out, Ben Cutting 20)

Lahore Qalandars 118 all out, 17.3 overs (Mirza Tahir Baig 45, Kamran Ghulam 23; Akif Javed 4-28, Ben Cutting 2-12, Aamer Yamin 2-18)

Player of the match – Imad Wasim (Karachi Kings)

Monday’s fixture

1900 – Quetta Gladiators v Peshawar Zalmi at the National Bank Cricket Arena, Karachi

For more information, contact:
Pakistan Super League (PSL)
Pakistan Super League Secretariat, Gaddafi Stadium,
Ferozepur Road, Lahore, Pakistan
Email: info@psl-t20.com
Website: http://www.psl-t20.com/

44% Pakistanis did not have any contact or experience with any government hospital in the past year: Gallup and Gilani Pakistan

Islamabad, February 20, 2023 (PPI-OT):According to a survey conducted by Gallup and Gilani Pakistan, 44% Pakistanis did not have any contact or experience with any government hospital in the past year.

A nationally representative sample of adult men and women from across the country, was asked the following as a follow up question, “In the last twelve months, have you experienced any of the following problems in a government hospital/clinic? – No contact experience with any government hospital/clinic in twelve months?” 44% responded yes while 56% said no.

Question: “In the last twelve months, have you experienced any of the following problems in a government hospital/clinic? – No contact experience with any government hospital/clinic in twelve months?”

For more information, contact:
Head Office,
Gallup Pakistan
Islamabad, Pakistan
Tel: +92-51-8445080
Email: isb@gallup.com.pk, caf@gallup.com.pk
Website: www.gallup.com.pk

ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages ESS Tech Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action Filed by the Firm – GWH

NEW YORK, Feb. 19, 2023 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of ESS Tech Inc. (NYSE: GWH) between August 11, 2022 and December 7, 2022, both dates inclusive (the “Class Period”), of the important March 13, 2023 lead plaintiff deadline.

SO WHAT: If you purchased ESS Tech securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the ESS Tech class action, go to https://rosenlegal.com/submit-form/?case_id=10877 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 13, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose, among other things, that: (1) the purported agreement with Energy Storage Industries Asia Pacific (“ESI”) was in fact an undisclosed related party transaction because ESI was a de-facto subsidiary of ESS masquerading as third-party client; (2) ESS misled investors with their partnership announcement to signal business success to investors; and (3) as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the ESS Tech class action, go to https://rosenlegal.com/submit-form/?case_id=10877 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm’s attorneys are ranked and recognized by numerous independent and respected sources. Rosen Law Firm has secured hundreds of millions of dollars for investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com

GlobeNewswire Distribution ID 8751976

ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Inspirato Incorporated Investors to Secure Counsel Before Important Deadline in First Filed Securities Class Action Commenced by the Firm – ISPO

NEW YORK, Feb. 19, 2023 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Inspirato Incorporated (NASDAQ: ISPO) between May 11, 2022 and December 15, 2022, both dates inclusive (the “Class Period”). A class action has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 17, 2023.

SO WHAT: If you purchased Inspirato securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Inspirato class action, go to https://rosenlegal.com/submit-form/?case_id=10246 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 17, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, Defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the Company’s unaudited condensed consolidated financial statements as of and for the quarterly periods ended March 31, 2022 and June 30, 2022 (collectively, the ‘Non-Reliance Periods’) included in the Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission (the ‘SEC’) for the Non-Reliance Periods, could no longer be relied upon; (2) the Quarterly Reports could no longer be relied upon due to the incorrect application of Accounting Standards Update (ASU) No. 2016-02, Leases (Topic 842) (‘ASC 842’) with respect to the assessment of right-of-use assets and liabilities, resulting in an understatement of both right-of-use assets and total lease liabilities of approximately 9% for each of the Non-Reliance Periods resulting in an understatement of total assets and total liabilities by approximately 5% for each of the Non-Reliance periods, and due to property-related and other expenses being under accrued in the first quarter, and over accrued in the second quarter, resulting in cost of revenue being understated by approximately 1% and overstated by approximately 5% in the first and second quarter, respectively (similarly, any previously issued or filed reports, press releases, earnings releases, and investor presentations or other communications describing the Company’s condensed consolidated unaudited financial statements and other related financial information covering the Non-Reliance Periods should no longer be relied upon); (3) the Company was not in compliance with the periodic filing requirements for continued listing set forth in Nasdaq Listing Rule 5250(c)(1) (the ‘Rule’) as a result of its failure to file its Quarterly Report on Form 10-Q for the quarter ended September 30, 2022 (the ‘Third Quarter Report’) with the Securities and Exchange Commission (the ‘SEC’) by the required due date; and (4) as a result, defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Inspirato class action, go to https://rosenlegal.com/submit-form/?case_id=10246 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm’s attorneys are ranked and recognized by numerous independent and respected sources. Rosen Law Firm has secured hundreds of millions of dollars for investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————

Contact Information:

        Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com

GlobeNewswire Distribution ID “8752037

ROSEN, A TOP RANKED FIRM, Encourages BioLineRx Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action Filed by the Firm – BLRX

NEW YORK, Feb. 19, 2023 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of BioLineRx Ltd. (NASDAQ: BLRX) between February 23, 2021 and September 19, 2022, both dates inclusive (the “Class Period”), of the important March 6, 2023 lead plaintiff deadline.

SO WHAT: If you purchased BioLine securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the BioLine class action, go to https://rosenlegal.com/submit-form/?case_id=8781 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 6, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose, among other things, that: (1) the Company was not well financed to develop Motixafortide while at the same time advancing other pipeline programs; (2) BioLine would require a loan from Kreos Capital VII Aggregator SCSP in an aggregate principal amount of up to $40 million and then also would require a $15M securities offering to facilitate the commercial launch of Motixafortide; and (3) as a result of the foregoing, defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the truth emerged, the lawsuit claims that investors suffered damages.

To join the BioLine class action, go to https://rosenlegal.com/submit-form/?case_id=8781 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————

Contact Information:

        Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com

GlobeNewswire Distribution ID 8751927